Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Salmonella vaccines for use in humans: present and future perspectives.

Garmory HS, Brown KA, Titball RW.

FEMS Microbiol Rev. 2002 Nov;26(4):339-53. Review.

2.

Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.

Levine MM, Galen J, Barry E, Noriega F, Chatfield S, Sztein M, Dougan G, Tacket C.

J Biotechnol. 1996 Jan 26;44(1-3):193-6. Review.

PMID:
8717403
3.
4.

The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella.

Chatfield SN, Roberts M, Dougan G, Hormaeche C, Khan CM.

Parasitology. 1995;110 Suppl:S17-24. Review.

PMID:
7784125
5.

Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.

Levine MM, Hone D, Tacket C, Ferreccio C, Cryz S.

Res Microbiol. 1990 Sep-Oct;141(7-8):807-16. Review.

PMID:
2101470
6.

CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.

Tacket CO, Levine MM.

Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S20-3. Review.

7.

Rational design of Salmonella recombinant vaccines.

Cheminay C, Hensel M.

Int J Med Microbiol. 2008 Jan;298(1-2):87-98. Review.

PMID:
17888730
8.

Typhoid fever & vaccine development: a partially answered question.

Marathe SA, Lahiri A, Negi VD, Chakravortty D.

Indian J Med Res. 2012;135:161-9. Review.

9.

[Therapeutic intervention alternatives in cancer, using attenuated live bacterial vectors: Salmonella enterica as a carrier of heterologous molecules].

Hernández-Luna MA, Luria-Pérez R, Huerta-Yépez S.

Rev Invest Clin. 2013 Jan-Feb;65(1):65-73. Review. Spanish.

PMID:
23745445
10.
12.

[Use of recombinant Salmonella strains for supplying the macro-organism with biologically active molecules].

Bondarenko VM, Beliavskaia VA, Vorob'ev AA.

Zh Mikrobiol Epidemiol Immunobiol. 2002 May-Jun;(3):70-9. Review. Russian.

PMID:
12141046
13.

Intracellular bacteria as targets and carriers for vaccination.

Mollenkopf H, Dietrich G, Kaufmann SH.

Biol Chem. 2001 Apr;382(4):521-32. Review.

PMID:
11405217
14.

Prospects for prevention of Salmonella infection in children through vaccination.

McGregor AC, Waddington CS, Pollard AJ.

Curr Opin Infect Dis. 2013 Jun;26(3):254-62. doi: 10.1097/QCO.0b013e32835fb829. Review.

PMID:
23591641
15.

Use of Salmonella for heterologous gene expression and vaccine delivery systems.

Hackett J.

Curr Opin Biotechnol. 1993 Oct;4(5):611-5. Review.

PMID:
7764214
16.

Development of acquired immunity to Salmonella.

Mastroeni P, Ménager N.

J Med Microbiol. 2003 Jun;52(Pt 6):453-9. Review.

PMID:
12748263
17.

Use of genetically modified bacteria to modulate adaptive immunity.

Bueno SM, González PA, Kalergis AM.

Curr Gene Ther. 2009 Jun;9(3):171-84. Review.

PMID:
19519362
18.

Salmonella enterica as a vaccine carrier.

Hegazy WA, Hensel M.

Future Microbiol. 2012 Jan;7(1):111-27. doi: 10.2217/fmb.11.144. Review.

PMID:
22191450
19.

Salmonella vaccines: lessons from the mouse model or bad teaching?

Strugnell RA, Scott TA, Wang N, Yang C, Peres N, Bedoui S, Kupz A.

Curr Opin Microbiol. 2014 Feb;17:99-105. doi: 10.1016/j.mib.2013.12.004. Review.

PMID:
24440968
20.

Protective host immune responses to Salmonella infection.

Pham OH, McSorley SJ.

Future Microbiol. 2015;10(1):101-10. doi: 10.2217/fmb.14.98. Review.

Items per page

Supplemental Content

Support Center